Owens & Minor ROE 2006-2020 | OMI

Current and historical return on equity (ROE) values for Owens & Minor (OMI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Owens & Minor ROE for the three months ending March 31, 2020 was 7.44%.
Owens & Minor ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2020-03-31 $-0.06B $0.42B -12.65%
2019-12-31 $-0.06B $0.46B -12.70%
2019-09-30 $-0.28B $0.49B -56.57%
2019-06-30 $-0.29B $0.50B -49.55%
2019-03-31 $-0.46B $0.50B -70.24%
2018-12-31 $-0.44B $0.52B -55.83%
2018-09-30 $-0.15B $0.79B -16.87%
2018-06-30 $-0.14B $0.80B -14.69%
2018-03-31 $0.06B $1.02B 6.15%
2017-12-31 $0.07B $1.02B 7.33%
2017-09-30 $0.08B $1.00B 7.84%
2017-06-30 $0.10B $0.99B 9.82%
2017-03-31 $0.10B $0.97B 10.53%
2016-12-31 $0.11B $0.96B 10.94%
2016-09-30 $0.11B $0.99B 11.35%
2016-06-30 $0.11B $1.00B 11.16%
2016-03-31 $0.11B $1.01B 10.91%
2015-12-31 $0.10B $0.99B 10.50%
2015-09-30 $0.09B $0.99B 8.67%
2015-06-30 $0.06B $0.98B 6.49%
2015-03-31 $0.06B $0.97B 6.00%
2014-12-31 $0.07B $0.99B 6.50%
2014-09-30 $0.08B $1.01B 7.81%
2014-06-30 $0.10B $1.03B 9.87%
2014-03-31 $0.11B $1.03B 10.85%
2013-12-31 $0.11B $1.03B 11.10%
2013-09-30 $0.11B $1.01B 10.94%
2013-06-30 $0.10B $0.99B 10.66%
2013-03-31 $0.11B $0.98B 10.88%
2012-12-31 $0.11B $0.97B 11.31%
2012-09-30 $0.11B $0.96B 11.37%
2012-06-30 $0.12B $0.95B 12.50%
2012-03-31 $0.12B $0.94B 12.58%
2011-12-31 $0.11B $0.92B 12.66%
2011-09-30 $0.11B $0.91B 12.65%
2011-06-30 $0.11B $0.90B 12.67%
2011-03-31 $0.11B $0.88B 12.97%
2010-12-31 $0.11B $0.86B 13.32%
2010-09-30 $0.12B $0.84B 15.05%
2010-06-30 $0.12B $0.82B 15.88%
2010-03-31 $0.12B $0.79B 15.75%
2009-12-31 $0.11B $0.77B 14.35%
2009-09-30 $0.09B $0.75B 12.93%
2009-06-30 $0.08B $0.71B 11.95%
2009-03-31 $0.08B $0.70B 12.19%
2008-12-31 $0.09B $0.69B 13.97%
2008-09-30 $0.10B $0.68B 14.69%
2008-06-30 $0.09B $0.66B 14.55%
2008-03-31 $0.09B $0.64B 14.07%
2007-12-31 $0.07B $0.61B 12.33%
2007-09-30 $0.06B $0.59B 10.05%
2007-06-30 $0.05B $0.57B 9.01%
2007-03-31 $0.04B $0.55B 7.71%
2006-12-31 $0.05B $0.55B 8.92%
2006-09-30 $0.06B $0.55B 10.76%
2006-06-30 $0.06B $0.53B 11.57%
2006-03-31 $0.07B $0.53B 13.02%
2005-12-31 $0.07B $0.51B 13.17%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.466B $9.211B
Owens & Minor, Inc. is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor's customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, the federal government, and healthcare patients at home through the Byram Healthcare subsidiary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $165.688B 28.73
Medtronic (MDT) Ireland $120.891B 19.64
Stryker (SYK) United States $66.633B 21.63
Boston Scientific (BSX) United States $48.278B 22.70
Baxter (BAX) United States $43.462B 26.53
Lonza Group Ag (LZAGY) Switzerland $42.008B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $28.981B 0.00
Terumo (TRUMY) Japan $28.231B 36.09
ResMed (RMD) United States $28.021B 44.22
Zimmer Biomet Holdings (ZBH) United States $24.281B 15.28
Sunny Optical Technology (SNPTF) China $20.840B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.828B 0.00
Bio-Rad Laboratories (BIO) United States $14.172B 64.51
Insulet (PODD) United States $13.329B 1320.56
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $10.288B 80.85
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
GN STORE NORD (GNNDY) Denmark $7.676B 39.13
Perrigo (PRGO) Ireland $7.396B 13.23
Hill-Rom Holdings (HRC) United States $7.394B 20.84
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $5.620B 0.00
Haemonetics (HAE) United States $4.381B 26.31
Neogen (NEOG) United States $4.079B 69.10
GW Pharmaceuticals (GWPH) United Kingdom $3.977B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.923B 0.00
ICU Medical (ICUI) United States $3.761B 27.44
Agios Pharmaceuticals (AGIO) United States $3.676B 0.00
Envista Holdings (NVST) United States $3.138B 0.00
NuVasive (NUVA) United States $2.743B 22.03
TG Therapeutics (TGTX) United States $2.661B 0.00
National Vision Holdings (EYE) United States $2.237B 38.71
AtriCure (ATRC) United States $1.768B 0.00
MacroGenics (MGNX) United States $1.508B 0.00
NanoString Technologies (NSTG) United States $1.361B 0.00
Aurora Cannabis (ACB) Canada $1.333B 0.00
Aphria (APHA) Canada $1.206B 0.00
Cerus (CERS) United States $1.148B 0.00
Meridian Bioscience (VIVO) United States $1.069B 40.24
Cardiovascular Systems (CSII) United States $1.042B 0.00
Vapotherm (VAPO) United States $1.014B 0.00
Phibro Animal Health (PAHC) United States $0.996B 19.85
PetIQ (PETQ) United States $0.961B 27.75
DFB Healthcare Acquisitions (AHCO) United States $0.890B 148.08
OraSure Technologies (OSUR) United States $0.860B 173.13
Zynex (ZYXI) United States $0.853B 85.70
InMode (INMD) Israel $0.853B 18.02
Quanterix (QTRX) United States $0.779B 0.00
Omeros (OMER) United States $0.731B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.646B 46.29
BioLife Solutions (BLFS) United States $0.572B 162.82
VAREX IMAGING (VREX) United States $0.571B 14.18
Lantheus Holdings (LNTH) United States $0.571B 11.49
Surmodics (SRDX) United States $0.562B 67.75
LeMaitre Vascular (LMAT) United States $0.521B 29.67
Viemed Healthcare (VMD) United States $0.413B 36.62
Cytosorbents (CTSO) United States $0.368B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.343B 0.00
HEXO (HEXO) $0.328B 0.00
Utah Medical Products (UTMD) United States $0.302B 21.90
Organigram Holdings (OGI) Canada $0.262B 0.00
InfuSystems Holdings (INFU) United States $0.224B 124.11
Female Health (VERU) United States $0.209B 0.00
Chimerix (CMRX) United States $0.192B 0.00
Surface Oncology (SURF) United States $0.161B 0.00
Bovie Medical (APYX) United States $0.158B 0.00
Fonar (FONR) United States $0.134B 11.83
Exagen (XGN) United States $0.133B 0.00
Rockwell Medical (RMTI) United States $0.122B 0.00
United Health Products (UEEC) United States $0.117B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.114B 0.00
Liberty Health Sciences (LHSIF) Canada $0.108B 0.00
Wound Management Technologies (SMTI) United States $0.104B 0.00
Evolus (EOLS) United States $0.102B 0.00
MTech Acquisition (KERN) United States $0.096B 0.00
Chembio Diagnostics (CEMI) United States $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.080B 0.00
Nephros (NEPH) United States $0.068B 0.00
United-Guardian (UG) United States $0.066B 15.32
Capricor Therapeutics (CAPR) United States $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 0.00
Brainsway (BWAY) Israel $0.060B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00